Melatonin can alter blood-pressure control, so a person with dementia should not start it until a clinician or pharmacist reviews the exact medicine. Monitoring should cover blood-pressure changes, standing dizziness, fainting, daytime drowsiness, and falls. Melatonin is a hormone-based sleep aid, while antihypertensives are medicines that lower blood pressure. The dementia-specific interaction remains unproven, but older adults' fall risk makes cautious review and monitoring important.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Can melatonin raise or lower blood pressure?
- What does the dementia evidence show?
- What should be reviewed before the first dose?
- How should caregivers monitor after starting?
- When does monitoring need extra caution?
Can melatonin raise or lower blood pressure?
The effect can go in either direction. It may depend on the melatonin formulation, timing, duration, and the person's blood-pressure treatment. The clearest interaction signal involves nifedipine. In a crossover study of 47 people whose hypertension was controlled with nifedipine alone, 5 mg of melatonin nightly increased average 24-hour pressure after four weeks.
Systolic pressure rose 6.5 mm Hg and diastolic pressure rose 4.9 mm Hg, suggesting that melatonin impaired nifedipine's effect, according to the British Journal of Clinical Pharmacology study. Other evidence points toward possible reductions. In 16 untreated hypertensive men, 2.5 mg nightly for three weeks lowered sleeping pressure by 6/4 mm Hg, while a single dose had no effect. A later meta-analysis found no clear benefit overall and rated the evidence low to very low.
What does the dementia evidence show?
Research has not established that people with dementia have a unique blood-pressure interaction between melatonin and antihypertensives. Evidence from other populations cannot show exactly what will happen in dementia care. Benefits for sleep are also uncertain. A Cochrane review of five melatonin trials involving 253 people with Alzheimer's dementia found no evidence that melatonin improved sleep in the reviewed studies.
The U.S. National Center for Complementary and Integrative Health notes that melatonin may remain active longer in older adults and cause daytime drowsiness. It also reports that 2015 sleep-medicine guidelines recommended against melatonin for people with dementia. These concerns make the reason for using melatonin as important as the proposed dose.
What should be reviewed before the first dose?
The NHS advises people to tell a doctor or pharmacist about blood-pressure-lowering medicines before combining them with melatonin because an interaction is possible. The review should identify the exact drug, with particular attention to nifedipine.
Useful questions include: Caregivers should also mention previous dizziness, fainting, falls, unsteadiness, or marked daytime sleepiness. Do not independently reduce or skip blood-pressure medicine to compensate for a new reading.
- What sleep problem is melatonin intended to address?
- Which blood-pressure medicine is being taken?
- What melatonin dose and formulation are proposed?
- When should blood pressure be checked?
- Should readings be taken both lying down and standing?
How should caregivers monitor after starting?
Record a baseline before the first dose if the care team recommends home monitoring. Then follow the clinician's schedule and use the same method each time, including lying and standing readings when requested.
A simple log can capture: The National Institute on Aging advises checking blood pressure while lying and standing because postural hypotension—a pressure drop after standing—can cause unsteadiness and contribute to fall risk. Share the log with the prescriber or pharmacist rather than adjusting either medicine without guidance.
- Date, time, and blood-pressure reading
- Whether the reading was taken lying, sitting, or standing
- Melatonin dose and time taken
- Blood-pressure medicine and time taken
- Dizziness, weakness, unsteadiness, or fainting
When does monitoring need extra caution?
Extra caution is reasonable when the person already has unstable blood pressure, frequent falls, fainting, or substantial daytime sedation. A noticeable change after melatonin begins deserves prompt review, even if one isolated reading is not clearly high or low. Lewy body dementia requires particular attention.
Autonomic dysfunction commonly causes orthostatic hypotension, with dizziness or fainting, and affected people may be unusually sensitive to prescription and over-the-counter medicines. Report a collapse, fainting episode, fall, or new inability to stand safely to the care team promptly. Bring the medicine containers or an exact medication list to the review, including the melatonin product, dose, formulation, and timing.
